San Diego, CA, USA


Biotechnology · DeepTech · Health


5001+ employees


Series B

founded in


VelosBio is an operator of a clinical-stage biopharmaceutical company intended to develop novel, first-in-class, ROR1-directed therapeutics to transform the lives of patients with cancer. The company's ROR1-directed therapeutics is a cell-surface protein that is expressed on many hematologic and solid tumors but is absent from normal tissues, making it an attractive tumor-specific therapeutic target and has demonstrated positive preclinical results in tumor models, enabling institutions to get novel targeted therapies for use as monotherapy or in combination across a broad range of cancers. It was founded in 2017 and headquartered in San Diego, California.

Something looks off?
Open jobs at VelosBio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.